Cornell faculty honored for community-engaged innovation

Thirteen faculty members from across Cornell are being honored by the Einhorn Center for Community Engagement with this year’s Community-Engaged Practice and Innovation Awards

Around Cornell

$10.5 million gift to Cornell will fund research using Empire AI

The gift from philanthropist Tom Secunda, co-founder of Bloomberg L.P., will help fund artificial intelligence-related research at Cornell Tech in New York City and at the Cornell Ann S. Bowers College of Computing and Information Science in Ithaca.

Study: ‘Ball and chain’ mechanism inactivates key ion channel

A new study has unveiled a precise picture of how an ion channel found in most mammalian cells regulates its own function with a “ball-and-chain” channel-plugging mechanism, according to investigators at Weill Cornell Medicine.

AI system can analyze serial medical images

A new AI-based system for analyzing images taken over time can accurately detect changes and predict outcomes, which may be useful across a wide range of medical and scientific applications.

How to Beat the Winter Blues and More: A Q&A With Cornell Tech’s New Therapist Sarah Rubenstein-Gillis

In the fall of 2024, Cornell Tech welcomed a counselor, Sarah Rubenstein-Gillis, dedicated to students on its campus in New York City.

Around Cornell

A 24-year partnership transforms health care in Tanzania

Weill Cornell Medicine and Weill Bugando School of Medicine collaborate to strengthen medical education, health care and innovative global health research at both institutions.

Professor Wendy Ju Honored With Prestigious Association for Computing Machinery Award

Professor Wendy Ju has been awarded a place in the Class of 2025 of the prestigious Association for Computing Machinery Special Interest Group on Computer-Human Interaction Academy.

Around Cornell

Islet-transplantation procedure shows promises against T1 diabetes

Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study led by Weill Cornell Medicine investigators.

New therapy may effectively control HIV in Uganda

A multinational, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.